Austin, TX, June 4, 2018 (GLOBENEWSWIRE) – CherryCircle Software, Inc., a software company developing novel software solutions for the pharmaceutical and medical device manufacturing industries, announced the appointment of Pasquale (Pat) Sacco to the Company’s Advisory Board effective immediately. Pat Sacco is a Biotechnology Technical Operations Executive with extensive experience in leading and managing technical operations functions, within the biotech and life sciences industries. Throughout his 30+ year career, he has been recognized for leading organizations through rapid growth and transformation, while creating significant value by establishing a culture of continuous process improvement, lean operations, and sustainable regulatory compliance.
“We are very excited to have Pat join our Advisory Board,” said Yash Sabharwal, President & CEO. “Pat has decades of experience in pharmaceutical and biotech manufacturing and he brings a wealth of knowledge, complementing the very diverse skill set of the other members on the Advisory Board. We expect that Pat will play a key role in the development of our QbDVision solution as well as our strategic business efforts around this product.”
In his most recent role as SVP Biologics Manufacturing and Site Operations at Shire, Pat led the internal manufacturing organization and site operations, consisting of a 750+ staff, $400M operating budget, multiple plants and warehouses, all of which produced three commercial and several biologic products in clinical development. He is passionate about the advancement and implementation of best practices in pharmaceutical manufacturing. “This is a very exciting time in the Life Sciences industry. The software solutions being developed by the CherryCircle team for managing and integrating process design and development, knowledge management, data analytics, and CMC, all within a quality risk-based, QbD framework, have been needed in the industry for a long time,” said Pat. “I am truly excited about joining this endeavor and bringing my specific experience to assist with this development.”
QbDVision™ is a unique software solution developed by industry veterans focusing specifically on Quality-by-Design (QbD) and Data Integrity-by-Design (DIbD) principles to enable the development of drugs, medical devices, and software under the Pharma 4.0 paradigm. Together, QbD and DIbD enable the kind of quality risk management and pharmaceutical quality essential for the design and development of complex manufacturing processes that can meet regulatory requirements in the future. For more information about QbDVisionTM, visit our website.
About CherryCircle Software, Inc.
CherryCircle Software, Inc. and the QbDVision project were started by two serial entrepreneurs and pharmaceutical manufacturing and quality experts. Our mission is to build cloud-based software solutions using the latest technologies for the simple application of quality-by-design principles to the development of therapeutics and medical devices reducing development time and reducing the risk of encountering a systemic failure later in the development life cycle. For more information about the Company, please visit our website.